StratifAI

Berlin, Germany · Founded 2023 · Privately Held (backing)

Developer of a precision oncology platform designed to advance cancer diagnostics through next-generation biomarker discovery. StratifAI is based in Berlin, Germany and was founded in 2023. It has raised $16.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$16.3M
Last round
—

Who backs StratifAI?

14 investors
InvestorType
Creative Destruction LabOther
Picus CapitalVenture capital
Alven Capital PartnersVenture capital
Memorial Sloan Kettering Cancer CenterOther
Jens BegemannOther
Arve Capital—
Christopher Haarburger—
Collective Ventures (Other Capital Markets/Institutions)—
Debiopharm Innovation Fund—
Heliad—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

StratifAI investors

Free account
More of StratifAI with a free account
  • ·The complete investor list: 14 names
  • ·Watch StratifAI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like StratifAI. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View